 |
 |
|
|
|
| Argipressin Acetate CAS NO113-79-1 |
 |
| Argipressin Acetate CAS NO113-79-1 purity :98% min |
 |
| 113-79-1 |
 |
Argipressin Acetate
CAS NO113-79-1
purity :98% min
1 Appearance White powder Conforms
2 Solubility Soluble in water or acetic acid at a concentration of ¡Ã1mg/ml to give a clear, colorless solution Conforms
3 Identity Monoisotopic Mass:1084.2¡¾1.0 1084.8
4 Amino Acid Composition ¡¾15% of theoretical Conforms
5 Peptide Purity (By HPLC) >95.0% by area integration 99.4%
6 Related Substance(By HPLC) Total Impurities(%)<5.0% Largest Single Impurity(%)<1.0% 0.6% 0.3%
7 Acetate Content <15.0% 14.3%
8 Water Content(Karl Fischer) <5.0% 1.5%
9 Microbial limits <200 cfu/ g Conforms
10 Peptide Content(N determination) >80.0% 82.8%
11 Assay(By Anhydrous, Acetic Acid-free ) 95.0¢¦105.0% 98.1%
|
 |
USP31/EP
|
 |
Argipressin Acetate
CAS NO113-79-1
purity :98% min
1 Appearance White powder Conforms
2 Solubility Soluble in water or acetic acid at a concentration of ¡Ã1mg/ml to give a clear, colorless solution Conforms
3 Identity Monoisotopic Mass:1084.2¡¾1.0 1084.8
4 Amino Acid Composition ¡¾15% of theoretical Conforms
5 Peptide Purity (By HPLC) >95.0% by area integration 99.4%
6 Related Substance(By HPLC) Total Impurities(%)<5.0% Largest Single Impurity(%)<1.0% 0.6% 0.3%
7 Acetate Content <15.0% 14.3%
8 Water Content(Karl Fischer) <5.0% 1.5%
9 Microbial limits <200 cfu/ g Conforms
10 Peptide Content(N determination) >80.0% 82.8%
11 Assay(By Anhydrous, Acetic Acid-free ) 95.0¢¦105.0% 98.1%
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
